MODAFINIL vs MOGAMULIZUMAB-KPKC: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MODAFINIL vs MOGAMULIZUMAB-KPKC: Safety Overview
| Metric | MODAFINIL | MOGAMULIZUMAB-KPKC |
|---|---|---|
| Total FAERS Reports | 3,375 | 1,186 |
| Deaths Reported | 157 | 161 |
| Death Rate | 4.7% | 13.6% |
| Hospitalizations | 556 | 198 |
| Average Patient Age | 44.4 yrs | 67.9 yrs |
| % Female Patients | 62.0% | 17.6% |
| FDA Approval Date | Aug 16, 2017 | N/A |
| Manufacturer | Alembic Pharmaceuticals Limited | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |